These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3729354)
1. Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin. Thomas MG; Lang SD Antimicrob Agents Chemother; 1986 May; 29(5):945-7. PubMed ID: 3729354 [TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of Ro-15-8074, a new oral cephalosporin. Peeters M; Piot P J Antimicrob Chemother; 1985 Oct; 16(4):469-73. PubMed ID: 3877719 [TBL] [Abstract][Full Text] [Related]
3. In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins. Fass RJ; Helsel VL Antimicrob Agents Chemother; 1986 Sep; 30(3):429-34. PubMed ID: 3777906 [TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074. Aldridge KE; Schiro DD; Sanders CV Eur J Clin Microbiol; 1987 Oct; 6(5):564-9. PubMed ID: 3436316 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin. Simon C Infection; 1987; 15(2):122-4. PubMed ID: 3596808 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of RO 15-8074 and RO 19-5247. Valle T; Jalanko E; Scheinin L; Renkonen OV Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing. Beskid G; Fallat V; Siebelist J; Durkin JW; Lipschitz ER; McGarry DH J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746. Chin NX; Neu HC Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates. Jones RN; Fuchs PC; Barry AL; Ayers LW; Gerlach EH; Gavan TL Antimicrob Agents Chemother; 1986 Dec; 30(6):961-3. PubMed ID: 3492961 [TBL] [Abstract][Full Text] [Related]
10. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany. Bauernfeind A Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil. Bauernfeind A; Jungwirth R Infection; 1991; 19(5):353-62. PubMed ID: 1800377 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074). Neu HC; Chin NX; Labthavikul P Antimicrob Agents Chemother; 1986 Sep; 30(3):423-8. PubMed ID: 3490827 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites. Wise R; Andrews JM; Piddock LJ Antimicrob Agents Chemother; 1986 Jun; 29(6):1067-72. PubMed ID: 3729361 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefetamet (Ro 15-8074). Mittermayer H Eur J Clin Microbiol; 1986 Oct; 5(5):530-4. PubMed ID: 3490975 [No Abstract] [Full Text] [Related]
15. In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae. Ng WS; Chau PY; Leung YK; Wong PC Antimicrob Agents Chemother; 1985 Sep; 28(3):461-3. PubMed ID: 3935045 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807). Jones RN; Barry AL Antimicrob Agents Chemother; 1988 Apr; 32(4):443-9. PubMed ID: 3377457 [TBL] [Abstract][Full Text] [Related]
17. Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium. Verbist L; Jacobs J; Hens K Diagn Microbiol Infect Dis; 1991; 14(1):53-61. PubMed ID: 1901535 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of U-76,252 (CS-807), a new oral cephalosporin. Fass RJ; Helsel VL Antimicrob Agents Chemother; 1988 Jul; 32(7):1082-5. PubMed ID: 3190194 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of BAY v 3522, a new oral cephalosporin. Fass RJ Antimicrob Agents Chemother; 1990 Sep; 34(9):1855-7. PubMed ID: 2126697 [TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibilities of common pediatric pathogens to LY163892. Shelton S; Nelson JD Antimicrob Agents Chemother; 1988 Feb; 32(2):268-70. PubMed ID: 3129989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]